ConductScience.org, home

Paper304528

Cyclophosphamide inhibited B cell receptor regeneration as a basis for drug-induced tolerance;.

Shand FL and 1 other. Nature, 1978. Cited by 34 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cyclophosphamide inhibited B cell receptor regeneration as a basis for drug-induced tolerance;. Papers, record 304528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/304528

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclophosphamide inhibited B cell receptor regeneration as a basis for drug-induced tolerance;.
PubMed
Journal
Nature
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2019-06-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shand FLF L
2Howard JGJ G

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B-LymphocytesMajor topic
CyclophosphamideMajor topic
Immune ToleranceMajor topic
Immunologic CappingMajor topic
Receptors, Antigen, B-CellMajor topic
Animals
Antibodies, Anti-Idiotypic
Chlorambucil
Female
Male
Melphalan
Mice
Spleen
Time Factors

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
7,002,766Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.Immunology1980https://conductscience.org/library/papers/7002766PubMed
6,214,499Kinetics of the relation between suppressor and effector mechanisms in contact sensitivity in the guinea-pig.Immunology1982https://conductscience.org/library/papers/6214499PubMed
2,935,958Cancer chemotherapeutics as immunomodulators.Springer Semin Immunopathol1985https://conductscience.org/library/papers/2935958PubMed
159,263Depression of contact sensitivity by Pseudomonas aeruginosa-induced suppressor cells which affect the induction phase of immune response.Infect Immun1979https://conductscience.org/library/papers/159263PubMed
99,365Depression of contact sensitivity by enhancement of suppressor cell activity in Pseudomonas aeruginosa-injected mice.Infect Immun1978https://conductscience.org/library/papers/99365PubMed
33,118The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.Immunology1978https://conductscience.org/library/papers/33118PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/304528

GET https://conductscience.org/api/papers/v1/304528/authors